Microfabrication technologies for oral drug delivery

Advanced Drug Delivery Reviews

Volumn 64, Issue 6, 2012, Pages 496-507

  Sant, Shilpa ^a,b,c   Tao, Sarah L ^d   Fisher, Omar Z ^b,e   Xu, Qiaobing ^f   Peppas, Nicholas A ^g   Khademhosseini, Ali ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HARVARD UNIVERSITY   (United States)

^d New Technologies and Research and Development   (United States)

^e Massachusetts Institute of Technology   (United States)

^f Tufts University   (United States)

^g UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

In vitro models; Microdevices; Microfabrication; Microfluidics; Oral absorption; Oral drug delivery

Indexed keywords

BIOADHESIVES; CELL TYPES; CONTACT AREAS; DRUG DELIVERY APPLICATIONS; DRUG DELIVERY DEVICES; DRUG DELIVERY VEHICLES; DRUG DISCOVERY; GASTROINTESTINAL TRACT; IN-VITRO; INTESTINAL LINING; MICRO DEVICES; MICRO-FABRICATION TECHNIQUES; MICRO-FABRICATION TECHNOLOGY; MICROFABRICATED; ORAL ABSORPTION; ORAL DRUG DELIVERY; PERSONALIZED MEDICINES; RESERVOIR SYSTEMS; SHAPE AND SIZE; STIMULI-RESPONSIVE;

BIOMIMETICS; LITHOGRAPHY; MICROANALYSIS; MICROFABRICATION; MICROFLUIDICS; PHYSIOLOGICAL MODELS; TISSUE ENGINEERING;

DRUG DELIVERY;

AMYLOPECTIN; CARBOXYMETHYLCELLULOSE; CHITOSAN; DIMETICONE; MACROGOL; NANOWIRE; POLY(METHYL METHACRYLATE); POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID;

BIODEGRADABILITY; BIOMIMETICS; CELL TYPE; DIAGNOSTIC PROCEDURE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG RESEARCH; EXPERIMENTAL MODEL; GASTROINTESTINAL TRACT; HUMAN; INTESTINE BRUSH BORDER; INTESTINE MUCOSA; LAB ON A CHIP; MATERIAL COATING; MATHEMATICAL MODEL; MICROFLUIDIC ANALYSIS; MICROTECHNOLOGY; MUCOADHESION; NANOTECHNOLOGY; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

ADMINISTRATION, ORAL; ANIMALS; BIOMIMETICS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GASTROINTESTINAL TRACT; HUMANS; MICROFLUIDICS; MICROTECHNOLOGY; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS;

EID: 84859709092     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2011.11.013     Document Type: Review

References (124)

1. Peppas N.A., Carr D.A. Impact of absorption and transport on intelligent therapeutics and nanoscale delivery of protein therapeutic agents. Chem. Eng. Sci. 2009, 64:4553-4565.
2. Goldberg M., Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat. Rev. Drug Discov. 2003, 2:289-295.
3. Martinez M.N., Amidon G.L. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J. Clin. Pharmacol. 2002, 42:620-643.
4. Hauss D.J. Oral lipid-based formulations. Adv. Drug Deliv. Rev. 2007, 59:667-676.
5. Morishita M., Peppas N.A. Is the oral route possible for peptide and protein drug delivery. Drug Discov. Today 2006, 11:905-910.
6. Peppas N.A., Wood K.M., Blanchette J.O. Hydrogels for oral delivery of therapeutic proteins. Expert. Opin. Biol. Ther. 2004, 4:881-887.
7. Liechty W.B., Kryscio D.R., Slaughter B.V., Peppas N.A. Polymers for drug delivery systems. Annu. Rev. Chem. Biomol. 2010, Vol. 1(1):149-173.
8. Wong J.E., Gaharwar A.K., Müller-Schulte D., Bahadur D., Richtering W. Dual-stimuli responsive PNiPAM microgel achieved via layer-by-layer assembly: magnetic and thermoresponsive. J. Colloid Interface Sci. 2008, 324:47-54.
9. Siegel R.A., Gu Y.D., Lei M., Baldi A., Nuxoll E.E., Ziaie B. Hard and soft micro- and nanofabrication: an integrated approach to hydrogel-based biosensing and drug delivery. J. Control. Release 2010, 141:303-313.
10. Shaw K.J., Birch C., Hughes E.M., Jakes A.D., Greenman J., Haswell S.J. Microsystems for personalized biomolecular diagnostics. Eng. Life Sci. 2011, 11:121-132.
11. Kang L., Chung B.G., Langer R., Khademhosseini A. Microfluidics for drug discovery and development: from target selection to product lifecycle management. Drug Discov.Today 2008, 13:1-13.
12. Chung B.G., Kang L.F., Khademhosseini A. Micro- and nanoscale technologies for tissue engineering and drug discovery applications. Expert Opin. Drug Discov. 2007, 2:1653-1668.
13. Caldorera-Moore M., Peppas N.A. Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems. Adv. Drug Deliv. Rev. 2009, 61:1391-1401.
14. Xia Y., Rogers J.A., Paul K.E., Whitesides G.M. Unconventional methods for fabricating and patterning nanostructures. Chem. Rev. 1999, 99:1823-1848.
15. Qin D., Xia Y.N., Whitesides G.M. Soft lithography for micro- and nanoscale patterning. Nat. Protoc. 2010, 5:491-502.
16. Ainslie K.M., Desai T.A. Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing. Lab Chip 2008, 8:1864-1878.
17. Hilt J.Z., Peppas N.A. Microfabricated drug delivery devices. Int. J. Pharm. 2005, 306:15-23.
18. LaVan D.A., McGuire T., Langer R. Small-scale systems for in vivo drug delivery. Nat. Biotechnol. 2003, 21:1184-1191.
19. Staples M., Daniel K., Cima M.J., Langer R. Application of micro- and nano-electromechanical devices to drug delivery. Pharm. Res. 2006, 23:847-863.
20. Tao S.L., Desai T.A. Microfabricated drug delivery systems: from particles to pores. Adv. Drug Deliv. Rev. 2003, 55:315-328.
21. Santini J.T., Richards A.C., Scheidt R.A., Cima M.J., Langer R.S. Microchip technology in drug delivery. Ann. Med. 2000, 32:377-379.
22. Staples M. Microchips and controlled-release drug reservoirs. Wiley Interdiscipl. Rev. Nanomed. Nanobiotechnol. 2010, 2:400-417.
23. Santini J.T., Cima M.J., Langer R. A controlled-release microchip. Nature 1999, 397:335-338.
24. Grayson A.C., Voskerician G., Lynn A., Anderson J.M., Cima M.J., Langer R. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. J. Biomater. Sci. Polym. Ed. 2004, 15:1281-1304.
25. Richards Grayson A.C., Choi I.S., Tyler B.M., Wang P.P., Brem H., Cima M.J., Langer R. Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat. Mater. 2003, 2:767-772.
26. Amirouche F., Zhou Y., Johnson T. Current micropump technologies and their biomedical applications. Microsyst.Technol. 2009, 15:647-666.
27. Sewell W.F., Borenstein J.T., Chen Z., Fiering J., Handzel O., Holmboe M., Kim E.S., Kujawa S.G., McKenna M.J., Mescher M.M., Murphy B., Swan E.E., Peppi M., Tao S. Development of a microfluidics-based intracochlear drug delivery device. Audiol. Neurootol. 2009, 14:411-422.
28. Tasciotti E., Liu X., Bhavane R., Plant K., Leonard A.D., Price B.K., Cheng M.M., Decuzzi P., Tour J.M., Robertson F., Ferrari M. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat. Nanotechnol. 2008, 3:151-157.
29. Martin F.J., Melnik K., West T., Shapiro J., Cohen M., Boiarski A.A., Ferrari M. Acute toxicity of intravenously administered microfabricated silicon dioxide drug delivery particles in mice: preliminary findings. Drugs R&D 2005, 6:71-81.
30. Guan J., Ferrell N., James Lee L., Hansford D.J. Fabrication of polymeric microparticles for drug delivery by soft lithography. Biomaterials 2006, 27:4034-4041.
31. Guan J., He H., Hansford D.J., Lee L.J. Self-folding of three-dimensional hydrogel microstructures. J. Phys. Chem. B 2005, 109:23134-23137.
32. Guan J., He H., Lee L.J., Hansford D.J. Fabrication of particulate reservoir-containing, capsulelike, and self-folding polymer microstructures for drug delivery. Small 2007, 3:412-418.
33. Tao S.L., Desai T.A. Micromachined devices: the impact of controlled geometry from cell-targeting to bioavailability. J. Control. Release 2005, 109:127-138.
34. Canelas D.A., Herlihy K.P., DeSimone J.M. Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. Wiley Interdiscipl. Rev. Nanomed. Nanobiotechnol. 2009, 1:391-404.
35. Gratton S.E., Ropp P.A., Pohlhaus P.D., Luft J.C., Madden V.J., Napier M.E., DeSimone J.M. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11613-11618.
36. Acharya G., Shin C.S., McDermott M., Mishra H., Park H., Kwon I.C., Park K. The hydrogel template method for fabrication of homogeneous nano/microparticles. J. Control. Release 2010, 141:314-319.
37. Acharya G., McDermott M., Shin S.J., Park H., Park K. Hydrogel templates for the fabrication of homogeneous polymer microparticles. Meth. Mol. Biol. 2011, 726:179-185.
38. Glangchai L.C., Caldorera-Moore M., Shi L., Roy K. Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles. J. Control. Release 2008, 125:263-272.
39. Dendukuri D., Pregibon D.C., Collins J., Hatton T.A., Doyle P.S. Continuous-flow lithography for high-throughput microparticle synthesis. Nat. Mater. 2006, 5:365-369.
40. Champion J.A., Katare Y.K., Mitragotri S. Making polymeric micro- and nanoparticles of complex shapes. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:11901-11904.
41. Champion J.A., Mitragotri S. Shape induced inhibition of phagocytosis of polymer particles. Pharm. Res. 2009, 26:244-249.
42. Tao S.L., Desai T.A. Gastrointestinal patch systems for oral drug delivery. Drug Discov. Today 2005, 10:909-915.
43. Lai S.K., Wang Y.Y., Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev. 2009, 61:158-171.
44. Foraker A.B., Walczak R.J., Cohen M.H., Boiarski T.A., Grove C.F., Swaan P.W. Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers. Pharm. Res. 2003, 20:110-116.
45. Ahmed A., Bonner C., Desai T.A. Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery. J. Control. Release 2002, 81:291-306.
46. Tao S.L., Desai T.A. Microfabrication of multilayer, asymmetric, polymeric devices for drug delivery. Adv. Mater. 2005, 17:1625-1630.
47. Tao S.L., Popat K., Desai T.A. Off-wafer fabrication and surface modification of asymmetric 3D SU-8 microparticles. Nat. Protoc. 2006, 1:3153-3158.
48. Quake S.R., Scherer A. From micro- to nanofabrication with soft materials. Science 2000, 290:1536-1540.
49. Tao S.L., Lubeley M.W., Desai T.A. Bioadhesive poly(methyl methacrylate) microdevices for controlled drug delivery. J. Control. Release 2003, 88:215-228.
50. Tao S.L., Lubeley M.W., Desai T.A. Synthesis of cytoadhesive poly(methylmethacrylate) for applications in targeted drug delivery. J. Biomed. Mater. Res. A 2003, 67:369-375.
51. Ainslie K.M., Kraning C.M., Desai T.A. Microfabrication of an asymmetric, multi-layered microdevice for controlled release of orally delivered therapeutics. Lab Chip 2008, 8:1042-1047.
52. Ainslie K.M., Lowe R.D., Beaudette T.T., Petty L., Bachelder E.M., Desai T.A. Microfabricated devices for enhanced bioadhesive drug delivery: attachment to and small-molecule release through a cell monolayer under flow. Small 2009, 5:2857-2863.
53. Peppas N.A. Devices based on intelligent biopolymers for oral protein delivery. Int. J. Pharm. 2004, 277:11-17.
54. Huang Y.B., Leobandung W., Foss A., Peppas N.A. Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J. Control. Release 2000, 65:63-71.
55. Serra L., Domenech J., Peppas N.A. Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. Eur. J. Pharm. Biopharm. 2009, 71:519-528.
56. Peppas N.A., Little M.D., Huang Y. Bioadhesive controlled release systems. Handbook of Pharmaceutical Controlled Release Technology 2000, 255-269. Dekker, New York, NY. D.L. Wise, L. Brannon-Peppas, A.M. Klibanov, R.L. Langer, A.G. Mikos, N.A. Peppas, D.J. Trantolo, G.E. Wnek, M.J. Yaszemski (Eds.).
57. Morishita M., Goto T., Peppas N.A., Joseph J.I., Torjman M.C., Munsick C., Nakamura K., Yamagata T., Takayama K., Lowman A.M. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J. Control. Release 2004, 97:115-124.
58. Wood K.M., Stone G.M., Peppas N.A. The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models. Acta Biomater. 2010, 6:48-56.
59. Ichikawa H., Peppas N.A. Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers. J. Biomed. Mater. Res. A 2003, 67A:609-617.
60. Morishita M., Goto T., Nakamura K., Lowman A.M., Takayama K., Peppas N.A. Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats. J. Control. Release 2006, 110:587-594.
61. Morishita M., Goto M., Takayama K., Peppas N.A. Oral insulin delivery systems based on complexation polymer hydrogels. J. Drug Deliv Sci. Technol. 2006, 16:19-24.
62. Kamei N., Morishita M., Chiba H., Kavimandan N.J., Peppas N.A., Takayama K. Complexation hydrogels for intestinal delivery of interferon beta and calcitonin. J. Control. Release 2009, 134:98-102.
63. Lehr C.M. Lectin-mediated drug delivery: the second generation of bioadhesives. J. Control. Release 2000, 65:19-29.
64. Naisbett B., Woodley J. Binding of tomato lectin to the intestinal mucosa and its potential for oral drug delivery. Biochem. Soc. Trans. 1990, 18:879-880.
65. Wirth M., Kneuer C., Lehr C.M., Gabor F. Lectin-mediated drug delivery: discrimination between cytoadhesion and cytoinvasion and evidence for lysosomal accumulation of wheat germ agglutinin in the Caco-2 model. J. Drug Target. 2002, 10:439-448.
66. Wood K.M., Stone G., Peppas N.A. Lectin functionalized complexation hydrogels for oral protein delivery. J. Control. Release 2006, 116:e66-e68.
67. Wood K.M., Stone G.M., Peppas N.A. Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery. Biomacromolecules 2008, 9:1293-1298.
68. Henry S., McAllister D.V., Allen M.G., Prausnitz M.R. Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 1998, 87:922-925.
69. Kaushik S., Hord A.H., Denson D.D., McAllister D.V., Smitra S., Allen M.G., Prausnitz M.R. Lack of pain associated with microfabricated microneedles. Anesth. Analg. 2001, 92:502-504.
70. McAllister D.V., Allen M.G., Prausnitz M.R. Microfabricated microneedles for gene and drug delivery. Annu. Rev. Biomed. Eng. 2000, 2:289-313.
71. Lee J.W., Park J.H., Prausnitz M.R. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008, 29:2113-2124.
72. Park J.H., Allen M.G., Prausnitz M.R. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2004, 4:2654-2657.
73. Park J.H., Allen M.G., Prausnitz M.R. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J. Control. Release 2005, 104:51-66.
74. Park J.H., Allen M.G., Prausnitz M.R. Polymer microneedles for controlled-release drug delivery. Pharm. Res. 2006, 23:1008-1019.
75. Mahdavi A., Ferreira L., Sundback C., Nichol J.W., Chan E.P., Carter D.J., Bettinger C.J., Patanavanich S., Chignozha L., Ben-Joseph E., Galakatos A., Pryor H., Pomerantseva I., Masiakos P.T., Faquin W., Zumbuehl A., Hong S., Borenstein J., Vacanti J., Langer R., Karp J.M. A biodegradable and biocompatible gecko-inspired tissue adhesive. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2307-2312.
76. Martanto W., Moore J.S., Couse T., Prausnitz M.R. Mechanism of fluid infusion during microneedle insertion and retraction. J. Control. Release 2006, 112:357-361.
77. Martanto W., Moore J.S., Kashlan O., Kamath R., Wang P.M., O'Neal J.M., Prausnitz M.R. Microinfusion using hollow microneedles. Pharm. Res. 2006, 23:104-113.
78. Roxhed N., Samel B., Nordquist L., Griss P., Stemme G. Painless drug delivery through microneedle-based transdermal patches featuring active infusion. IEEE Trans. Biomed. Eng. 2008, 55:1063-1071.
79. Donnelly R.F., Raj Singh T.R., Woolfson A.D. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010, 17:187-207.
80. Arzt E., Gorb S., Spolenak R. From micro to nano contacts in biological attachment devices. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10603-10606.
81. Spolenak R., Gorb S., Arzt E. Adhesion design maps for bio-inspired attachment systems. Acta Biomater. 2005, 1:5-13.
82. Fischer K.E., Aleman B.J., Tao S.L., Hugh Daniels R., Li E.M., Bunger M.D., Nagaraj G., Singh P., Zettl A., Desai T.A. Biomimetic nanowire coatings for next generation adhesive drug delivery systems. Nano Lett. 2009, 9:716-720.
83. Mullard A. 2010 FDA drug approvals. Nat. Rev. Drug Discov. 2011, 10:82-85.
84. Park T.H., Shuler M.L. Integration of cell culture and microfabrication technology. Biotechnol. Prog. 2003, 19:243-253.
85. Moraes C., Mehta G., Lesher-Perez S., Takayama S. Organs-on-a-chip: a focus on compartmentalized microdevices. Ann. Biomed. Eng. 2011, 1-17.
86. Esch M.B., King T.L., Shuler M.L. The role of body-on-a-chip devices in drug and toxicity studies. Annu. Rev. Biomed. Eng. 2011, 13. null.
87. Huh D., Matthews B.D., Mammoto A., Montoya-Zavala M., Hsin H.Y., Ingber D.E. Reconstituting organ-level lung functions on a chip. Science 2010, 328:1662-1668.
88. Domansky K., Inman W., Serdy J., Dash A., Lim M.H.M., Griffith L.G. Perfused multiwell plate for 3D liver tissue engineering. Lab Chip 2010, 10:51-58.
89. Le Ferrec E., Chesne C., Artusson P., Brayden D., Fabre G., Gires P., Guillou F., Rousset M., Rubas W., Scarino M.L. In vitro models of the intestinal barrier - the report and recommendations of ECVAM Workshop 46. ATLA Altern. Lab. Anim. 2001, 29:649-668.
90. Gan L.-S.L., Thakker D.R. Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium. Adv. Drug Deliv. Rev. 1997, 23:77-98.
91. Yazdanian M., Glynn S.L., Wright J.L., Hawi A. Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm. Res. 1998, 15:1490-1494.
92. Artursson P. Epithelial transport of drugs in cell-culture.1. A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 1990, 79:476-482.
93. Wang L., Murthy S.K., Fowle W.H., Barabino G.A., Carrier R.L. Influence of micro-well biomimetic topography on intestinal epithelial Caco-2 cell phenotype. Biomaterials 2009, 30:6825-6834.
94. Wang L., Murthy S.K., Barabino G.A., Carrier R.L. Synergic effects of crypt-like topography and ECM proteins on intestinal cell behavior in collagen based membranes. Biomaterials 2010, 31:7586-7598.
95. Gunawan R.C., Choban E.R., Conour J.E., Silvestre J., Schook L.B., Gaskins H.R., Leckband D.E., Kenis P.J.A. Regiospecific control of protein expression in cells cultured on two-component counter gradients of extracellular matrix proteins. Langmuir 2005, 21:3061-3068.
96. Slaughter B.V., Khurshid S.S., Fisher O.Z., Khademhosseini A., Peppas N.A. Hydrogels in regenerative medicine. Adv. Mater. 2009, 21:3307-3329.
97. Sant S., Hancock M.J., Donnelly J.P., Iyer D., Khademhosseini A. Biomimetic gradient hydrogels for tissue engineering. Can. J. Chem. Eng. 2010, 88:899-911.
98. Lutolf M.P. Spotlight on hydrogels. Nat. Mater. 2009, 8:451-453.
99. Peppas N.A., Huang Y., Torres-Lugo M., Ward J.H., Zhang J. Physicochemical, foundations and structural design of hydrogels in medicine and biology. Annu. Rev. Biomed. Eng. 2000, 2:9-29.
100. Peppas N.A., Hilt J.Z., Khademhosseini A., Langer R. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv. Mater. 2006, 18:1345-1360.
101. Nichol J.W., Koshy S.T., Bae H., Hwang C.M., Yamanlar S., Khademhosseini A. Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials 2010, 31:5536-5544.
102. Aubin H., Nichol J.W., Hutson C.B., Bae H., Sieminski A.L., Cropek D.M., Akhyari P., Khademhosseini A. Directed 3D cell alignment and elongation in microengineered hydrogels. Biomaterials 2010, 31:6941-6951.
103. Sung J.H., Yu J., Luo D., Shuler M.L., March J.C. Microscale 3-D hydrogel scaffold for biomimetic gastrointestinal (GI) tract model. Lab Chip 2011, 11:389-392.
104. Imura Y., Asano Y., Sato K., Yoshimura E. A microfluidic system to evaluate intestinal absorption. Anal. Sci. 2009, 25:1403-1407.
105. Choi S.H., Nishikawa M., Sakoda A., Sakai Y. Feasibility of a simple double-layered coculture system incorporating metabolic processes of the intestine and liver tissue: application to the analysis of benzo a pyrene toxicity. Toxicol. Vitr. 2004, 18:393-402.
106. Lau Y.Y., Chen Y.-H., Liu T.-t., Li C., Cui X., White R.E., Cheng K.-C. Evaluation of a novel in vitro caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability. Drug Metab. Dispos. 2004, 32:937-942.
107. Choi S.H., Fukuda O., Sakoda A., Sakai Y. Enhanced cytochrome P450 capacities of Caco-2 and Hep G2 cells in new coculture system under the static and perfused conditions: evidence for possible organ-to-organ interactions against exogenous stimuli. Mater. Sci. Eng. C 2004, 24:333-339.
108. Mahler G.J., Esch M.B., Glahn R.P., Shuler M.L. Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity. Biotechnol. Bioeng. 2009, 104:193-205.
109. Mahler G.J., Shuler M.L., Glahn R.P. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability. J. Nutr. Biochem. 2009, 20:494-502.
110. Jang K.-J., Suh K.-Y. A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells. Lab Chip 2010, 10:36-42.
111. Jang K.-J., Cho H.S., Kang D.H., Bae W.G., Kwon T.-H., Suh K.-Y. Fluid-shear-stress-induced translocation of aquaporin-2 and reorganization of actin cytoskeleton in renal tubular epithelial cells. Integr. Biol. 2011, 3:134-141.
112. Ferrell N., Desai R.R., Fleischman A.J., Roy S., Humes H.D., Fissell W.H. A microfluidic bioreactor with integrated transepithelial electrical resistance (TEER) measurement electrodes for evaluation of renal epithelial cells. Biotechnol. Bioeng. 2010, 107:707-716.
113. Kimura H., Yamamoto T., Sakai H., Sakai Y., Fujii T. An integrated microfluidic system for long-term perfusion culture and on-line monitoring of intestinal tissue models. Lab Chip 2008, 8:741-746.
114. Yeon J.H., Park J.-K. Drug permeability assay using microhole-trapped cells in a microfluidic device. Anal. Chem. 2009, 81:1944-1951.
115. Brown R.P., Delp M.D., Lindstedt S.L., Rhomberg L.R., Beliles R.P. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Heal. 1997, 13:407-484.
116. Khamsi R. Labs on a chip meet the stripped down rat. Nature 2005, 435:12-13.
117. Sung J.H., Shuler M.L. In vitro microscale systems for systematic drug toxicity study. Bioprocess Biosyst. Eng. 2010, 33:5-19.
118. Sin A., Chin K.C., Jamil M.F., Kostov Y., Rao G., Shuler M.L. The design and fabrication of three-chamber microscale cell culture analog devices with integrated dissolved oxygen sensors. Biotechnol. Prog. 2004, 20:338-345.
119. Tatosian D.A., Shuler M.L. A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers. Biotechnol. Bioeng. 2009, 103:187-198.
120. Viravaidya K., Shuler M.L. Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies. Biotechnol. Prog. 2004, 20:590-597.
121. Viravaidya K., Sin A., Shuler M.L. Development of a microscale cell culture analog to probe naphthalene toxicity. Biotechnol. Prog. 2004, 20:316-323.
122. McAuliffe G.J., Chang J.Y., Glahn R.P., Shuler M.L. Development of a gastrointestinal tract microscale cell culture analog to predict drug transport. Mol. Cell. Biomech. 2008, 5. ISSN 1556-5297(print)|1556-5300(electronic).
123. Tao S.L., Desai T.A. Microdevices for oral drug delivery. BioMEMS and Biomedical Nanotechnology 2007, 237-261. Springer, US. M. Ferrari, T. Desai, S. Bhatia (Eds.).
124. Ainslie K.M., Kraning C.M., Desai T.A. Microfabrication of an asymmetric, multi-layered microdevice for controlled release of orally delivered therapeutics. Lab Chip 2008, 8:1042-1047.